Publication
Article
BioPharm International
BioPharm International-06-15-2016Volume2016 ebook Issue 1
Pages: 39–41
Outsourcing Industry Marked by Considerable Investments in 2016
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
The biopharmaceutical outsourcing industry has been marked by investment in technology and facility upgrades, mergers, acquisitions, and development partnerships in 2016. This article details are some of the latest developments in the biopharmaceutical outsourcing market.
Download the
BioPharm International 2016 Outsourcing Resources eBook.
Articles in this issue
Contract Service Providers Gear Up to Develop Emerging Therapies
Biopharma Service Providers Address a Full Plate of Challenges
Dealing with Pharmaceutical Supply-Chain Complexities
Keeping it Simple: Collaborating for Success in Drug Delivery
Regulatory Reform in China: Implications for Global Biopharmaceutical Companies
Biomanufacturers Demand Higher Quality Standards in 2016
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
